These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13924027)

  • 41. [ADAPTATION OF A TABLET DISINTEGRATION TESTER FOR USE IN THE ASSAY OF PEPSIN].
    IZGUE E
    Turk Hij Tecr Biyol Derg (1961); 1965; 25():41-52. PubMed ID: 14333898
    [No Abstract]   [Full Text] [Related]  

  • 42. Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties.
    Grossjohann C; Serrano DR; Paluch KJ; O'Connell P; Vella-Zarb L; Manesiotis P; Mccabe T; Tajber L; Corrigan OI; Healy AM
    J Pharm Sci; 2015 Apr; 104(4):1385-98. PubMed ID: 25605031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of crystalline formation and granulometric characters of some varieties of lactose and the products of lactose base on the properties of some tablet formulas].
    Jaminet F
    Pharm Acta Helv; 1968 Apr; 43(4):228-43. PubMed ID: 5718856
    [No Abstract]   [Full Text] [Related]  

  • 44. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
    Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
    Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Commercial use of para-aminosalicylic acid tablets].
    Medika (Zagreb); 1950; 3(7-8):100. PubMed ID: 14779767
    [No Abstract]   [Full Text] [Related]  

  • 46. EFFECT OF CERTAIN TABLET FORMULATION FACTORS ON DISSOLUTION RATE OF THE ACTIVE INGREDIENT. I. IMPORTANCE OF USING APPROPRIATE AGITATION INTENSITIES FOR IN VITRO DISSOLUTION RATE MEASUREMENTS TO REFLECT IN VIVO CONDITIONS.
    LEVY G
    J Pharm Sci; 1963 Nov; 52():1039-46. PubMed ID: 14079628
    [No Abstract]   [Full Text] [Related]  

  • 47. Analytical and pharmaceutical studies with para-aminosalicylic acid.
    OBERWEGER KH; SEYMOUR DE; SIMMONITE D
    Pharm J; 1948 Sep; 107(4429):193. PubMed ID: 18885632
    [No Abstract]   [Full Text] [Related]  

  • 48. [DIELECTRIC DETERMINATION OF MOISTURE IN SOLID FORMS OF DRUGS WITH THE "SUPER BEHA" MEASUREMENT DEVICE].
    FRAUCH P; LANG E
    Pharm Acta Helv; 1963 Sep; 38():676-89. PubMed ID: 14052361
    [No Abstract]   [Full Text] [Related]  

  • 49. Formulation of water disinfectant tablets for rural communities in Nigeria.
    Sridhar MK; Jaiyeoba KT; Ashefor HO
    Afr J Med Med Sci; 1994 Jun; 23(2):181-5. PubMed ID: 7625309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of an oral rutin nanocrystal formulation.
    Mauludin R; Müller RH; Keck CM
    Int J Pharm; 2009 Mar; 370(1-2):202-9. PubMed ID: 19114097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Punch geometry and formulation considerations in reducing tablet friability and their effect on in vitro dissolution.
    Chowhan ZT; Amaro AA; Ong JT
    J Pharm Sci; 1992 Mar; 81(3):290-4. PubMed ID: 1640370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [THE AMPEROMETRIC DETERMINATION OF SOME BARBITURIC ACID DERIVATIVES IN TABLETS].
    BERAL H; WERMESCHER B; MUREA L; MADGEARU M; CUCIUREANU E
    Pharm Zentralhalle Dtschl; 1964; 103():112-6. PubMed ID: 14218733
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum concentration studies with sustained-action para-aminosalicylic acid tablets.
    SMALL MJ; KIRMAN D; ALLEN RL
    Am Rev Tuberc; 1958 Jan; 77(1):184-8. PubMed ID: 13498307
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the behavior of the p-amino-salicylic acid and isonicotinic acid hydrazid system in aqueous solutions].
    WILLI AV; FISCHER R
    Med Exp Int J Exp Med; 1960; 3():321-8. PubMed ID: 13785381
    [No Abstract]   [Full Text] [Related]  

  • 55. [PHYSICOCHEMICAL STUDIES ON WATER CONTAINED IN SOLID MEDICAMENTS. I. RELATION BETWEEN APPARENT DIELECTRIC CONSTANT OF COMPRESSED TABLET AND CONTAINED WATER].
    HORIKOSHI I; SANO H
    Yakugaku Zasshi; 1964 Sep; 84():851-6. PubMed ID: 14247813
    [No Abstract]   [Full Text] [Related]  

  • 56. Formulation of tablets containing an 'in-process' amorphized active pharmaceutical ingredient.
    Jójárt-Laczkovich O; Szabó-Révész P
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1272-81. PubMed ID: 21457129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specificity of the relationship between rate of dissolution and disintegration time of compressed tablets.
    SCHROETER LC; TINGSTAD JE; KNOECHELEL ; WAGNER JG
    J Pharm Sci; 1962 Sep; 51():865-74. PubMed ID: 13909342
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of pulverization of the bulk powder on the hydration of creatine anhydrate tablets and their pharmaceutical properties.
    Sakata Y; Shiraishi S; Otsuka M
    Colloids Surf B Biointerfaces; 2005 Dec; 46(2):92-100. PubMed ID: 16274970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of crystal hydration on the mechanical properties of sodium naproxen.
    Joiris E; Di Martino P; Malaj L; Censi R; Barthélémy C; Odou P
    Eur J Pharm Biopharm; 2008 Sep; 70(1):345-56. PubMed ID: 18539444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elucidation of Compression-Induced Surface Crystallization in Amorphous Tablets Using Sum Frequency Generation (SFG) Microscopy.
    Mah PT; Novakovic D; Saarinen J; Van Landeghem S; Peltonen L; Laaksonen T; Isomäki A; Strachan CJ
    Pharm Res; 2017 May; 34(5):957-970. PubMed ID: 27738954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.